Status:
TERMINATED
Shift to Everolimus (RAD) Kidney Sparing Study
Lead Sponsor:
University of Bologna
Conditions:
Kidney Dysfunction
Heart Transplantation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to verify if the combination of Everolimus with a very low dose of cyclosporine is more effective than the combination of mycophenolate mofetil with low-dose of cyclospori...
Eligibility Criteria
Inclusion
- Heart Transplant with 1 to 4 years of follow-up
- GFR between 20 and 60 ml/min (calculated with Colkoroft-Gault formula)
Exclusion
- Acute rejection in the previous 6 months
- Contraindications to statin therapy
- Ongoing infection
- Ongoing heart failure
- Myocardial infarction or myocardial revascularization after transplant
- Malignancy
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00420537
Start Date
September 1 2006
End Date
March 1 2009
Last Update
January 12 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico S.Orsola-Malpighi
Bologna, Italy, 40138